Final Overall Survival Analysis of the TOURMALINE-MM1 Phase III Trial of Ixazomib, Lenalidomide, and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma

Richardson, P.G. ✉; Kumar, S.K.; Masszi, T. [Masszi, Tamás (Belgyógyászat, ha...), author] III. Department of Internal Medicine (SU / FM / C); Grzasko, N.; Bahlis, N.J.; Hansson, M.; Pour, L.; Sandhu, I.; Ganly, P.; Baker, B.W.; Jackson, S.R.; Stoppa, A.-M.; Gimsing, P.; Garderet, L.; Touzeau, C.; Buadi, F.K.; Laubach, J.P.; Cavo, M.; Darif, M.; Labotka, R.; Berg, D.; Moreau, P.